| Source: |
| Type: |
| AntiTumor |
| 7765- | ISL, | Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications |
| - | Review, | Var, | NA |
| 7786- | ISL, | Isoliquiritigenin exhibits anti-proliferative properties in the pituitary independent of estrogen receptor function |
| - | in-vitro, | Var, | NA |
| 9253- | ISO, IH, | Progress in the antitumor molecular mechanisms of Isorhamnetin |
| - | Review, | Var, | NA |
| 8038- | IVM, | Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction |
| - | in-vitro, | PC, | NA |
| 8036- | IVM, | Ivermectin inhibits the growth of ESCC by activating the ATF4-mediated endoplasmic reticulum stress-autophagy pathway |
| - | in-vitro, | ESCC, | KYSE-30 |
| 8025- | IVM, | Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth |
| - | in-vitro, | CRC, | SW480 | - | in-vivo, | CRC, | HCT116 |
| 8049- | IVM, | Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer |
| - | vitro+vivo, | BC, | NA |
| 8095- | KAE, | Kaempferol: A Key Emphasis to Its Anticancer Potential |
| - | Review, | Var, | NA |
| 8100- | KAE, | Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways |
| - | in-vitro, | Cerv, | HeLa |
| 8058- | KAE, | A randomized, placebo‐controlled trial evaluating the safety of excessive administration of kaempferol aglycone |
| - | Trial, | Nor, | NA |
| 8076- | KAE, | Kaempferol suppresses prostate cancer metastasis and tumor angiogenesis via disrupting the LIMK1/Cofilin pathway |
| - | in-vivo, | Pca, | NA |
| 8077- | KAE, | Kaempferol exerts anti-colorectal cancer effects through its multi-target mediated glucose metabolism remodeling |
| - | in-vitro, | CRC, | NA |
| 8114- | LA, | Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate |
| - | in-vitro, | Cerv, | HeLa |
| 8246- | LCA, | Licochalcone A activates Keap1-Nrf2 signaling to suppress arthritis via phosphorylation of p62 at serine 349 |
| - | in-vivo, | Arthritis, | NA |
| 8243- | LCA, | Licochalcone A Inhibits Cellular Motility by Suppressing E-cadherin and MAPK Signaling in Breast Cancer |
| - | in-vitro, | BC, | MDA-MB-231 |
| 8253- | LCA, | Licochalcone A, a natural chalconoid isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1 and Sp1 regulatory proteins in oral squamous cell carcinoma |
| - | in-vitro, | SCC, | HSC4 |
| 8255- | LCA, | Antitumor and antimetastatic effects of licochalcone A in mouse models |
| - | in-vivo, | Colon, | NA |
| 8275- | LCA, | Licochalcone A inhibits glioma migration, invasion, and growth by triggering mitochondrial dysfunction and ROS-mediated oxidative damage |
| - | vitro+vivo, | GBM, | NA |
| 8206- | LCA, | Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways |
| - | in-vivo, | GC, | BGC-823 |
| 8218- | LCA, | Advances in Pharmacological Activities and Drug Delivery Systems of Licochalcone A |
| - | Review, | Nor, | NA |
| 8268- | LE, | Glycyrrhizin Attenuates Carcinogenesis by Inhibiting the Inflammatory Response in a Murine Model of Colorectal Cancer |
| - | vitro+vivo, | CRC, | NA |
| 8277- | LE, | Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: Molecular insights |
| - | Review, | Var, | NA |
| 8139- | LF, | Androgen Receptor‐Induced Lactoferrin Accelerates Prostate Tumorigenesis Through Modulating Ferroptosis |
| - | vitro+vivo, | Pca, | NA |
| 8191- | LGE, | Lemongrass (Cymbopogon citratus (D.C.) Stapf) Presents Antitumoral Effect and Improves Chemotherapy Activity in Prostate Cancer Cells |
| - | in-vitro, | Pca, | DU145 |
| 8295- | lign, | Distribution, biosynthesis and therapeutic potential of lignans |
| - | Review, | Var, | NA |
| 8395- | LT, | PacT, | Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma |
| - | in-vitro, | ESCC, | NA |
| 2543- | M-Blu, | The use of methylene blue to control the tumor oxygenation level |
| - | in-vivo, | Lung, | NA |
| 4528- | MAG, | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
| - | Review, | Nor, | NA |
| 4526- | MAG, | HNK, | Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis |
| - | Review, | Var, | NA |
| 8556- | Matr, | Matrine alleviates spatial learning and memory impairment in diabetic mice by inhibiting endoplasmic reticulum stress and through modulation of PK2/PKRs pathway |
| - | in-vivo, | AD, | NA | - | in-vivo, | Diabetic, | NA |
| 8555- | Matr, | Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review |
| - | Review, | Var, | NA |
| 8551- | Matr, | Research Progress of Natural Matrine Compounds and Synthetic Matrine Derivatives |
| - | Review, | Nor, | NA |
| 8547- | Matr, | Matrine in cancer therapy: antitumor mechanisms and nano-delivery strategies |
| - | Review, | Var, | NA |
| 8925- | MBS, | A review on metabolites and pharmaceutical potential of food legume crop mung bean (Vigna radiata L. Wilczek) |
| - | Review, | Var, | NA |
| 8645- | MBZ, | HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo |
| - | vitro+vivo, | Colon, | CT26 |
| 8626- | MBZ, | The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells |
| - | in-vitro, | Lung, | NA |
| 8818- | MCP, | Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model |
| - | in-vivo, | CRC, | NA |
| 8622- | MCT, | Decanoic Acid Exerts Its Anti-Tumor Effects via Targeting c-Met Signaling Cascades in Hepatocellular Carcinoma Model |
| - | vitro+vivo, | HCC, | NA |
| 3464- | MF, | Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology |
| - | Review, | Var, | NA |
| 9155- | MG, MIC-1, | The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo |
| - | in-vivo, | Mye, | NA |
| 1786- | MLT, | What is known about melatonin, chemotherapy and altered gene expression in breast cancer (Review) |
| - | Review, | BC, | NA |
| 8660- | MLT, | Unraveling the impact of melatonin treatment: Oxidative stress, metabolic responses, and morphological changes in HuH7.5 hepatocellular carcinoma cells |
| - | in-vitro, | CCA, | HuH28 |
| 3837- | MO, | Moringa oleifera: A Tree of Life as a Promising Medicinal Plant for Neurodegenerative Diseases |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 8906- | MOR, | Morin, a avonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB-231 partly through suppression of the Akt pathway |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 8943- | MushCha, | Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice |
| - | in-vivo, | Lung, | NA |
| 8957- | mushLions, | Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review |
| - | Review, | Nor, | NA |
| 9306- | MushMait, | Maitake (D fraction) mushroom extract induces apoptosis in breast cancer cells by BAK-1 gene activation |
| - | in-vitro, | BC, | MCF7 |
| 5604- | NaHCO3, | Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity |
| - | vitro+vivo, | Melanoma, | B16-BL6 | - | in-vitro, | BC, | 4T1 |
| 1797- | NarG, | Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway |
| - | in-vitro, | BC, | MDA-MB-231 |
| 1807- | NarG, | A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:913 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid